|
⚲
|
| Farallon Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001463270 |
| Sale | 2009-05-19 ($8.0 M Offered, $4.0 M Sold) |
| Fund | |
| Phone | 8585506088 |
| Address | 2825 Crystal Ridge Road Encinitas, 92024 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Richard Heyman | |
| Peter Svennilson | |
| Carl Gordon |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ARX Investimentos LTDA
✚
|
0.0 | |
|
AS-0312 Fund I, a series of Sajid Rahman Angel Funds, LP
✚
|
0.0 | |
|
Asbury Valerie L.
✚
|
0.0 | |
|
AS Capital, Inc.
✚
|
0.0 | |
|
ASC Dental Ventures LLC
✚
|
0.0 | |
|
Ascellus Health, Inc.
✚
|
0.0 | |
|
Ascendant Front Capital Fund I LP
✚
|
0.0 | |
|
Ascend Capital Partners Fund I-FF, L.P.
✚
|
0.0 | |
|
Ascend Equity Fund LLC
✚
|
0.0 | |
|
Pbvmf 23 LLC
✚
|
0.0 |